HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
AUPH
Aurinia Pharmaceuticals Inc
Healthcare Biotechnology · British Columbia, Canada · Reports in usd
Market Cap: $2.11B
Market Cap
$2.11B
Enterprise Val
$1.78B
P/E Ratio
7.34
P/B Ratio
3.62
Trailing PEG (1Y)
0.00
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$581.3M
Gross Margin88.59%
Profit Margin88.59%
Return on Equity70.37%
Return on Assets50.24%
Current Ratio5.25
Debt/Equity0.13
LT Debt/Equity0.10
Revenue Per Share0.58

Income Statement

Dec 31, 2025
Revenue$77.1M
Cost of Revenue$8.8M
Gross Profit$68.3M
R&D$10.9M
SG&A$29.3M
Operating Expenses$35.1M
Operating Income$33.2M
Interest Expense$1.0M
Tax Expense-$175.1M
Net Income$210.8M
EPS (Basic)$1.57
EPS (Diluted)$1.52
EBIT$36.7M
EBITDA$41.6M
Consolidated Income$210.8M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$80.2M
Accounts Receivable$41.5M
Inventory$45.7M
Current Assets$492.0M
LT Investments$0.00
Property, Plant & Equipment$79.6M
Intangibles$3.8M
Non-Current Assets$259.6M
Total Assets$751.6M
Accounts Payable$3.3M
Current Debt$17.6M
Current Liabilities$93.7M
LT Debt$57.2M
Non-Current Liabilities$76.5M
Total Liabilities$170.3M
Total Debt$74.8M
Retained Earnings-$649.4M
Shareholder Equity$581.3M
Shares Outstanding131,840,559

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$45.7M
Investing Cash Flow-$36.8M
Financing Cash Flow-$1.9M
CapEx-$72.0K
Free Cash Flow$45.6M
Depreciation & Amort.$4.9M
Stock-Based Comp$6.7M
Acquisitions / Disposals$0.00
Investment Activity-$36.7M
Debt Issued/Repaid-$3.5M
Equity Issued/Repaid$2.0M
Dividends Paid$0.00
Net Change in Cash$7.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h